Tonix Pharmaceuticals Holding (TNXP) Cash from Operations (2023 - 2025)
Historic Cash from Operations for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to -$28.8 million.
- Tonix Pharmaceuticals Holding's Cash from Operations fell 5308.76% to -$28.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$74.8 million, marking a year-over-year decrease of 901.73%. This contributed to the annual value of -$60.9 million for FY2024, which is 4027.14% up from last year.
- According to the latest figures from Q3 2025, Tonix Pharmaceuticals Holding's Cash from Operations is -$28.8 million, which was down 5308.76% from -$14.8 million recorded in Q2 2025.
- In the past 5 years, Tonix Pharmaceuticals Holding's Cash from Operations ranged from a high of -$9.9 million in Q2 2024 and a low of -$32.9 million during Q1 2023
- Moreover, its 3-year median value for Cash from Operations was -$18.8 million (2024), whereas its average is -$20.3 million.
- In the last 5 years, Tonix Pharmaceuticals Holding's Cash from Operations soared by 5755.12% in 2024 and then plummeted by 5308.76% in 2025.
- Over the past 3 years, Tonix Pharmaceuticals Holding's Cash from Operations (Quarter) stood at -$22.3 million in 2023, then soared by 34.51% to -$14.6 million in 2024, then crashed by 96.73% to -$28.8 million in 2025.
- Its Cash from Operations was -$28.8 million in Q3 2025, compared to -$14.8 million in Q2 2025 and -$16.6 million in Q1 2025.